NEXENTIS TECHNOLOGIES INC. Operating Loss Carryforwards
NEXENTIS TECHNOLOGIES INC. (NXTS) had Operating Loss Carryforwards of $37.33 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Operating Loss Carryforwards $37.33M.
- 2024-12-31: Operating Loss Carryforwards $31.20M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $37.33M 10-K · filed 2026-03-31 |
| 2024-12-31 | $31.20M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |